The Singaporean state-owned firm will acquire a minority stake in Alphabet's life sciences spinout and will take a board seat in the process.
Singaporean state-owned investment firm Temasek agreed yesterday to pay $800m for a minority stake in Verily Life Sciences, a US-based healthcare technology spinout of internet technology conglomerate Alphabet.
Originally formed as part of Google’s Google X research division and named Google Life Sciences, Verily was spun out as an independent company in 2015 when Google restructured its operations under the umbrella of holding company Alphabet.
Verily conducts life science research, seeking to apply technologies such as data organisation and analytics…
